one
characterist
featur
vacuolar
system
secretori
plasma
membran
protein
travel
compos
order
array
membranebound
compart
newli
synthes
protein
enter
system
rough
endoplasm
reticulum
el
travel
vectori
fashion
ci
medial
tran
golgi
cisterna
complex
organel
system
refer
tram
golgi
network
rout
lysosom
secretori
granul
plasma
membran
via
vesicl
either
matur
fuse
endstag
organel
organel
pathway
distinct
characterist
compon
function
specif
process
enzym
catalyz
reaction
within
organel
modifi
protein
creat
signatur
reach
particular
destin
along
pathway
massiv
movement
protein
along
pathway
rais
question
individu
organel
along
pathway
maintain
distinct
properti
face
continu
flow
membran
compart
must
dynam
state
allow
retent
uniqu
resid
protein
must
also
mechan
preserv
total
membran
content
surfac
area
organel
problem
particularli
signific
er
bulk
flow
measur
rothman
colleagu
suggest
half
lipid
remov
everi
min
without
compar
rate
de
novo
synthesi
wieland
et
al
two
possibl
suggest
lipid
return
er
poster
compart
like
ci
golgi
vesicular
recycl
rothman
farquhar
cytosol
transfer
nonvesicular
lipid
golgi
er
wieland
et
al
vesicular
recycl
would
import
implic
mechan
retent
er
protein
warren
resid
er
protein
might
mere
anchor
er
retain
face
enorm
flow
membran
er
nonvesicular
lipid
recycl
model
would
predict
instead
select
retriev
retain
protein
ci
golgi
back
er
might
occur
suggest
one
recent
studi
pelham
learn
mechan
regul
membran
flow
er
use
brefeldin
bfa
afung
antibacteri
reagent
report
inhibit
transport
protein
er
misumi
et
al
studi
demonstr
addit
prevent
protein
leav
er
treatment
cell
bfa
profound
effect
structur
cislmedi
golgi
within
minut
bfa
treatment
cislmedi
golgi
compon
redistribut
becom
part
er
subsequ
redistribut
process
carbohydr
chain
erretain
glycoprotein
cislmedi
golgi
enzym
observ
tran
golgi
marker
contrast
show
redistribut
er
bfa
treatment
also
observ
carbohydr
process
erretain
protein
could
attribut
tran
golgi
effect
bfa
rapidli
revers
upon
remov
drug
minut
remov
bfa
golgi
protein
rapidli
transport
er
newli
reform
golgi
apparatu
erresid
protein
mix
remain
er
addit
export
protein
recov
abil
transport
er
golgi
apparatu
onto
distal
target
organel
result
simpli
explain
model
bfa
interfer
dynam
membranerecycl
pathway
er
cislmedi
golgi
use
cell
antigen
receptor
tcr
studi
effect
bfa
intracellular
protein
transport
receptor
multimer
protein
complex
compos
least
seven
transmembran
chain
p
chain
form
disulfidelink
heterodim
function
antigen
recognit
noncoval
associ
five
chain
e
homodim
samelson
et
al
four
tcr
subunit
contain
nlink
carbohydr
chain
newli
synth
size
tcr
subunit
assembl
rapidli
pentamer
afir
heptamer
complex
er
transport
golgi
apparatu
either
lysosom
ie
pentam
cell
surfac
ie
heptam
minami
et
al
sussman
et
al
bfa
effect
assembl
tcr
subunit
multimer
complex
lippincottschwartz
unpublish
data
drug
dramat
effect
ultim
fate
subcellular
distribut
complex
describ
retent
tcr
chain
er
bfrtreat
cell
biochem
data
sever
research
group
suggest
bfa
lipophil
compound
structur
heterocycl
lacton
harri
et
al
inhibit
transport
protein
er
golgi
system
misumi
et
al
takatsuki
tamura
odaet
al
identifi
site
blockad
bfa
intracellular
transport
tcr
chain
cell
use
morpholog
approach
murin
cell
hybridoma
cell
treat
without
bfa
pglml
sandoz
co
switzerland
variou
time
period
result
intracellular
distribut
tcr
chain
examin
immunofluoresc
immunoelectron
microscopi
shown
immunofluoresc
figur
upper
left
tcr
control
cell
detect
anti
antibodi
distribut
primarili
larg
phasedens
vesicl
identifi
lysosom
electron
microscopi
see
faint
stain
plasma
membran
also
observ
doubl
label
cell
antibodi
erresid
protein
figur
upper
right
show
virtual
coincid
two
marker
result
subcellular
distribut
tcr
e
chain
consist
previou
studi
laboratori
major
tcr
chain
observ
assembl
partial
pentamer
complex
ie
ap
rapidli
transport
er
golgi
complex
lysosom
degrad
small
subset
tcr
complex
assembl
complet
heptamer
complex
target
cell
surfac
minami
et
al
sussman
et
al
addit
pglml
bfa
cultur
medium
caus
dramat
chang
overal
cellular
distribut
tcr
cell
three
hour
addit
antibiot
immunofluoresc
stain
lysosom
anti
antibodi
longer
detect
figur
lower
left
instead
fine
reticular
stain
pattern
along
nuclear
membran
throughout
cytoplasm
observ
costain
antibodi
erresid
protein
figur
lower
right
reveal
almost
complet
coincid
two
label
pattern
reticular
stain
pattern
antia
antibodi
greatli
reduc
protein
synthesi
inhibitor
cycloheximid
includ
medium
shown
result
suggest
bfa
treatment
caus
newli
synthes
econtain
tcr
retain
er
loss
stain
antic
antibodi
lysosom
structur
bfa
treatment
presum
due
lysosom
degrad
e
chain
sinc
bfa
reportedli
inhibitori
effect
lysosom
degrad
misumi
et
al
morpholog
result
similar
figur
obtain
use
antibodi
tcr
chain
indic
transport
tcr
chain
er
also
block
bfa
treatment
data
shown
differ
tcr
subunit
affect
similarli
bfa
expect
sinc
complet
tcr
complex
apya
assembl
normal
bfatreat
cell
thu
chang
subcellular
distribut
one
receptor
chain
detect
tcr
e
chain
cell
cell
incub
hr
presenc
absenc
bfa
ml
cell
fix
permeabil
saponin
label
anti
antibodi
follow
hapconjug
goat
antihamst
igg
reaction
diaminobenzidin
hydrochlorid
hso
cell
prepar
electron
microscopi
cytoplasm
untreat
cell
show
distribut
hrp
reaction
product
primarili
lysosom
faint
label
plasma
membran
golgi
apparatu
er
includ
nuclear
membran
also
detect
bar
urn
hrpposit
structur
bfatreat
cell
intens
label
er
cisterna
nuclear
envelop
observ
contrast
littl
label
lysosom
golgi
apparatu
plasma
membran
detect
bar
e
urn
abbrevi
nu
nucleu
er
endoplasm
reticulum
ly
lysosom
antibodi
specif
chain
reflect
distribut
tcr
chain
assembl
complex
effect
bfa
subcellular
distribut
scontain
tcr
confirm
ultrastructur
level
use
immunoperoxidas
electron
microscopi
control
cell
figur
horseradish
peroxidas
hap
stain
observ
primarili
lysosom
gofgi
complex
slight
stain
plasma
membran
region
er
nuclear
membran
also
detect
bfa
treatment
littl
hrp
stain
associ
lysosom
golgi
apparatu
cell
surfac
instead
heavi
stain
detect
along
ribosomestud
er
cisterna
nuclear
membran
along
vesicular
reticular
er
consist
block
transport
ccontain
tcr
er
morpholog
er
golgi
complex
affect
bfa
treatment
er
cisterna
variabl
swollen
golgi
stack
longer
clearli
visibl
morpholog
intracellular
organel
howev
includ
lysosom
mitochondria
nucleu
chang
result
bfa
treatment
golgi
enzym
bfa
ate
cell
bfa
inhibit
transport
tcr
er
one
would
predict
oligosaccharid
side
chain
receptor
glycoprotein
subunit
would
process
golgispecif
enzym
initi
appear
case
sinc
chain
pulsechas
cell
process
matur
molecular
mass
kd
observ
control
cell
figur
top
inde
examin
effect
neuraminidas
electrophoret
mobil
bfatreat
cell
figur
reveal
hr
biosynthet
puls
chain
modifi
sialic
acid
requir
transport
fran
golgi
compart
kornfeld
kornfeld
b
cell
treat
without
bfa
min
pulselabel
min
chase
complet
medium
hr
chase
cell
deterg
solubil
immunoprecipit
antia
antibodi
boil
min
sodium
phosphat
buffer
ph
contain
mm
edta
incub
hr
presenc
absenc
mu
neuraminidas
calbiochembehr
corp
la
jolla
ca
sampl
analyz
nephgusdspag
reduc
condit
cleavag
neuraminidas
sialic
acid
residu
matur
oligosaccharid
chain
control
cell
result
shift
migrat
chain
acid
basic
ph
compar
shift
migrat
chain
bfatreat
cell
observ
indic
chain
modifi
sialic
acid
valu
indic
left
oligosaccharid
chain
protein
uarentino
maley
convers
highmannos
complex
oligosaccharid
occur
medial
golgi
sequenti
activ
nacetylglucosaminyltransferas
mannosidas
ii
kornfeld
kornfeld
shown
figur
bottom
newli
synthes
tcr
chain
began
show
endo
h
resist
within
min
biosynthesi
bfatreat
cell
hr
chase
oligosaccharid
chain
bfatreat
cell
becom
complet
resist
endo
h
control
cell
note
chain
progress
lost
control
bfatreat
cell
former
chain
transport
degrad
lysosom
lippincottschwartz
et
al
latter
case
chain
subject
er
degrad
bfa
inhibit
lippincottschwartz
et
al
unpublish
data
chain
tcr
well
also
contain
nlink
carbohydr
residu
show
evid
process
cislmedi
golgi
enzym
bfatreat
cell
roughli
chain
carbohydr
becam
endo
h
resist
hr
chase
see
test
whether
acquisit
endo
h
resist
tcr
oligosaccharid
chain
due
process
golgispecif
enzym
mere
prolong
exposur
chain
resid
er
mannosidas
examin
effect
swainsonin
oligosaccha
hr
treatment
control
presenc
swainsonin
ml
swainsonin
bfa
pgml
bfa
bfa
plu
swainsonin
bfa
swain
ceil
pulselabel
ss
methionin
io
min
chase
hr
medium
use
lize
immunoprecipk
antiantibodi
treat
without
endo
h
analysi
sdspage
reduc
condit
valu
indic
left
ride
process
event
swainsonin
specif
inhibit
action
golgi
mannosidas
ii
prevent
remov
al
mannosyl
residu
necessari
acquisit
endo
h
resist
elbein
et
al
tulsiani
et
al
cell
preincub
hr
medium
contain
either
addit
swainsonin
bfa
bfa
plu
swainsonin
cell
metabol
pulselabel
min
chase
hr
medium
use
preincub
lmmunoprecipit
endo
h
digest
perform
analyz
nlink
carbohydr
structur
tcr
subunit
shown
figur
swainsonin
block
appear
endo
hresist
oligosaccharid
control
bfatreat
cell
thu
endo
hresist
form
bfatreat
cell
aris
activ
golgi
mannosidas
ii
resid
er
mannosidas
result
present
appar
paradox
tcr
complex
cell
normal
capabl
rapid
effici
transport
er
golgi
apparatu
bfa
treatment
tcr
local
almost
exclus
er
determin
morpholog
studi
suggest
receptor
never
transport
er
presenc
drug
biochem
studi
howev
suggest
passag
receptor
ci
medial
golgi
bfa
treatment
sinc
tcr
obtain
signatur
ie
endo
h
resist
protein
reach
compart
one
resolut
paradox
would
bfa
allow
movement
tcr
medial
golgi
block
transport
tran
golgi
instead
rerout
tcr
complex
back
er
process
fast
tcr
would
accumul
er
consist
morpholog
observ
bfatreat
cell
investig
possibl
turn
two
cell
line
tcr
chain
transport
golgi
system
variant
synthes
tcr
chain
except
bonifacino
et
al
unpublish
data
murin
cell
tumor
line
fail
synthes
chain
absenc
one
subunit
tcr
subunit
cell
fail
negoti
ertogolgi
transport
presum
due
inabl
oligomer
properli
tcr
glycoprotein
cell
never
becom
endo
h
resist
morpholog
criteria
resid
er
see
sinc
tcr
cell
normal
never
transport
golgi
acquisit
endo
h
resist
bfa
treatment
would
predict
hypothesi
effici
movement
golgi
rapid
retriev
er
cell
therefor
pulsechas
methionin
presenc
absenc
bfa
tcr
glycoprotein
immunoprecipit
treat
without
endo
h
figur
untreat
cell
expect
glycoprotein
remain
endo
h
sensit
throughout
chase
period
surprisingli
bfatreat
cell
newli
synthes
chain
becam
endo
h
resist
time
evid
bfa
treatment
result
golgilik
carbohydr
process
protein
retain
er
examin
resid
er
protein
glycoprotein
uniqu
found
retain
within
er
character
green
colleagu
demonstr
remain
er
time
synthesi
golgi
process
carbohydr
chain
lewi
et
al
predomin
form
nlink
carbohydr
managlcnacp
cell
pulselabel
methionin
min
chase
hr
presenc
absenc
kgml
bfa
immunoprecipit
antipeptid
antibodi
precipit
either
mocktreat
digest
endo
h
subject
sdspolyacrylamid
gel
electrophoresi
sdspage
control
cell
protein
ident
sensit
endo
h
end
puls
hr
chase
bfatreat
cell
sensit
endo
h
end
puls
show
shift
respons
endo
h
chase
figur
demonstr
bfa
caus
process
resid
er
protein
golgi
enzym
togeth
result
inconsist
hypothesi
bfa
act
sole
block
transport
protein
medial
van
golgi
sinc
protein
retain
er
well
export
protein
becom
modifi
golgi
enzym
presenc
drug
altern
explan
bfa
effect
would
inhibit
protein
transport
er
allow
newli
synthes
golgi
enzym
like
mannosidas
ii
accumul
er
could
explain
erresid
protein
becom
modifi
otherwis
golgispecif
enzym
presenc
bfa
test
hypothesi
look
effect
cycloheximid
protein
synthesi
inhibitor
extent
carbohydr
process
tcr
chain
bfatreat
cell
acquisit
endo
h
resist
tcr
glycoprotein
bfatreat
cell
due
sole
activ
newli
synthes
mannosidas
ii
becom
trap
er
bfa
block
protein
synthesi
prior
bfa
treatment
prevent
allow
newli
synthes
protein
like
mannosidas
ii
clear
er
figur
show
result
experi
design
test
possibl
carbohydr
process
cell
tcr
chain
glycoprotein
retain
er
cell
studi
cell
metabol
pulselabel
min
incub
hr
complet
medium
alon
hr
medium
contain
bfa
hr
medium
contain
cycloheximid
follow
hr
medium
contain
bfa
plu
cycloheximid
chain
glycoprotein
immunoprecipit
variou
time
chase
treat
without
endo
h
shown
figur
cycloheximid
prevent
process
oligosaccharid
chain
endo
hresist
form
cell
treat
bfa
even
though
lower
quantiti
newli
synthes
mannosidas
ii
occur
er
cell
compar
control
cell
latter
oligosaccharid
chain
remain
endo
h
sensit
cycloheximid
slow
kinet
process
slow
carbohydr
process
prolong
treatment
drug
seen
control
cell
absenc
bfa
unpublish
observ
thu
newli
synthes
mannosidas
ii
min
incub
hr
complet
medium
alon
control
hr
complet
medium
contain
bfa
pgml
bfa
hr
complet
medium
contain
cycloheximid
pgml
sigma
hr
medium
contain
bfa
plu
cycloheximid
bfa
chx
treatment
cell
ml
cycloheximid
result
inhibit
protein
synthesi
indic
time
point
chase
start
hr
end
puls
time
cell
deterg
solubil
immunoprecipit
antiy
antibodi
lmmunoprecipit
treat
without
endo
h
analysi
sdspage
reduc
condit
valu
indic
left
zyme
redistribut
golgi
apparatu
er
test
possibl
examin
morpholog
distribut
cislmedi
golgi
marker
mannosidas
ii
dunphi
rothman
farquhar
kornfeld
kornfeld
use
antibodi
enzym
cell
treat
without
bfa
shown
figur
upper
left
immunofluoresc
stain
mannosidas
ii
permeabil
normal
rat
kidney
nrk
cell
reveal
intens
label
larg
perinuclear
structur
characterist
golgi
apparatu
min
treatment
bfa
howev
distribut
mannosidas
ii
chang
dramat
entir
popul
golgi
enzym
dispers
fine
punctat
reticulum
distribut
throughout
cytoplasm
figur
lower
left
lmmunoperoxidas
electron
microscopi
perform
identifi
ultrastructur
level
intracellular
compart
mannosidas
ii
redistribut
bfa
treatement
rat
basophil
leukemia
rbl
cell
use
purpos
sinc
stain
mannosidas
ii
antibodi
greater
cell
cell
test
howev
pattern
stain
redistribut
essenti
ident
cell
see
fibroblast
rbl
cell
shown
figur
hrp
reaction
product
control
rbl
cell
local
almost
entir
ci
medial
golgi
cisterna
bfa
treatment
figur
virtual
hrpposit
golgi
cisterna
could
detect
cell
instead
hrp
stain
local
within
nuclear
membran
along
ribosomestud
er
cisterna
within
vesicular
reticular
element
er
label
lysosom
mitochondria
multivesicular
bodi
plasma
membran
observ
bfatreat
cell
cell
pretreat
cycloheximid
block
new
protein
synthesi
morpholog
redistribut
mannosidas
ii
observ
result
indic
presenc
bfa
mannosidas
ii
longer
local
golgi
cisterna
redistribut
dramat
er
distribut
differ
golgi
markermannosidas
ia
primarili
ci
golgi
compon
dunphi
et
al
golgi
also
redistribut
er
upon
exposur
bfa
immunofluoresc
stain
reveal
mannosidas
ia
distribut
chang
predominantli
golgilik
stain
pattern
reticular
er
label
pattern
upon
bfa
treat
nrk
cell
incub
bfa
rglml
control
min
hr
altern
nrk
cell
incub
hr
bfa
chase
fresh
untreat
medium
min
hr
allow
recoveri
bfa
treatment
cell
fix
permeabil
saponin
label
antimannosidas
ii
antibodi
wash
remov
unbound
igg
cell
incub
rhodaminelabel
goat
antirabbit
igg
label
specif
bound
antimannosidas
ii
antibodi
final
wash
cell
prepar
microscopi
photograph
rhodamin
optic
bar
wm
ment
shown
result
combin
ultrastructur
observ
rais
possibl
cislmediai
golgi
complex
becom
part
er
bfa
treatment
segreg
cislmedi
an
goigi
bfalkeat
cell
contrast
distribut
mannosidas
ia
ii
distribut
tran
golgi
glycoprotein
detect
immunofluoresc
stain
wheat
germ
aggiutinin
wga
chang
signficantli
bfa
treatment
wga
bind
cluster
termin
nacetylneuramin
acid
residu
well
nacetyiglucosaminecontain
oligosaccharid
chain
protein
tartakoff
vassaiii
result
label
cisterna
along
distal
face
goigi
stack
associ
vesicl
ceil
surfac
virtanen
et
al
costain
nrk
cell
mannosidas
ii
fluoresc
label
wga
figur
reveal
mix
stain
pattern
golgi
associ
vesicl
wga
contrast
mannosidas
ii
stain
cislmediai
goigi
plasma
membran
stain
fluoresc
wga
block
preincub
intact
cell
unlabel
wga
upon
bfa
treatment
littl
chang
stain
pattern
wga
occur
contrast
mannosidas
ii
morpholog
studi
use
monoclonai
antibodi
direct
resid
integr
membran
protein
fran
goigi
yuan
et
al
confirm
wga
result
demonstr
tram
goigi
redistribut
cislmedi
golgi
respons
bfa
data
shown
result
suggest
bfa
exert
profound
effect
structur
goigi
apparatu
effect
caus
spatial
segreg
cislmedi
compon
redistribut
er
tram
golgi
show
local
er
rapid
reassembl
golgi
remov
bfa
redistribut
mannosidas
ii
er
ceil
treat
bfa
rapid
depict
morpholog
figur
within
min
bfa
treatment
virtual
entir
popul
mannosidas
ii
nrk
fibroblast
redistribut
perinuciear
golgi
stain
pattern
punctat
reticular
er
stain
pattern
chang
observ
longer
incub
presenc
bfa
reassembl
goigi
apparatu
tightli
organ
perinuclear
structur
found
control
ceil
occur
rapidli
upon
remov
bfa
cell
shown
figur
mannosidas
ii
almost
complet
redistribut
diffus
reticularvesicular
pattern
characterist
er
central
perinuclear
structur
within
min
remov
bfa
hr
stain
pattern
mannosidas
ii
show
larg
perinuclear
structur
indistinguish
control
ceil
ikansport
tcr
chain
restor
upon
remov
bfa
test
whether
inhibitori
effect
bfa
intracellular
transport
sort
tcr
chain
could
fulli
revers
upon
remov
lipophil
drug
examin
subcellular
distribut
tcr
anti
chain
antibodi
bfa
treatment
use
ceil
tumor
line
purpos
sinc
former
ceil
type
tcr
complex
normal
rapidli
transport
er
golgi
apparatu
latter
complex
normal
fail
leav
er
experi
cycloheximid
use
block
new
protein
synthesi
thu
cell
treat
bfa
hr
reincub
fresh
medium
contain
nglml
cycloheximid
hr
recoveri
left
untreat
control
cell
fix
permeabil
saponin
doubl
label
anti
antibodi
plu
antibodi
er
protein
anti
antibodi
plu
antibodi
mannosidas
ii
wash
remov
unbound
igg
cell
incub
rhodaminelabel
goat
antihamst
igg
label
specif
bound
e
antibodi
fluoresceinlabel
goat
antirabbit
igg
label
specif
bound
erdirect
antimannosidas
ii
antibodi
final
wash
cell
prepar
microscopi
bar
urn
nofluoresc
chang
remov
bfa
reflect
true
redistribut
tcr
protein
lmmunofluoresc
stain
tcr
e
chain
cell
figur
left
reveal
chain
resid
er
bfa
treatment
bfa
remov
chain
redistribut
throughout
secretori
pathway
steadi
state
indistinguish
distribut
control
cell
recov
control
cell
tcr
e
chain
local
predominantli
larg
vesicl
correspond
lysosom
golgi
contrast
fine
reticularvesicular
network
found
bfa
treatment
doubl
label
cell
antibodi
mannosidas
ii
reveal
redistribut
golgi
enzym
er
upon
bfa
treatment
observ
nrk
rbl
cell
likewis
remov
bfa
result
transport
mannosidas
ii
er
golgi
cisterna
doubl
label
recov
cell
antibodi
tcr
e
chain
erresid
protein
demonstr
erresid
protein
tcr
e
chain
mannosidas
ii
mix
bfa
treatment
remain
er
thu
remov
bfa
result
rapid
effici
sort
membran
compon
er
lmmunofluoresc
stain
tcr
e
chain
cell
figur
right
reveal
essenti
chang
distribut
tcr
chain
bfa
treatment
time
stain
tcr
e
chain
reticularnetwork
pattern
characterist
er
doubl
label
cell
antibodi
erresid
protein
bottom
right
two
panel
confirm
local
e
er
bfainduc
redistribut
mannosidas
ii
recoveri
upon
remov
drug
ident
cell
altogeth
result
suggest
bfa
perman
effect
mechan
intracellular
traffick
protein
cell
sinc
sort
resid
er
protein
ie
e
chain
cell
export
protein
ie
e
chain
cell
restor
upon
remov
drug
studi
report
grew
attempt
resolv
appar
paradox
set
observ
effect
bfa
fate
glycoprotein
subunit
tcr
immunofluoresc
immunoelectron
microscopi
demonstr
bfa
treatment
cell
result
accumul
tcr
chain
er
suggest
bfa
block
protein
transport
er
contrast
biochem
analysi
carbohydr
side
chain
tcr
subunit
bfatreat
cell
indic
process
manner
consist
movement
medial
golgi
particular
subunit
becam
resist
cleavag
enzym
endo
h
normal
occur
glycoprotein
move
er
medial
golgi
golgispecif
enzym
mannosidas
ii
nacetylglucosaminyltransferas
convert
oligosaccharid
side
chain
endo
hresist
complex
form
abil
swainsonin
specif
inhibitor
golgi
mannosidas
ii
block
acquisit
endo
h
resist
bfatreat
cell
support
conclus
obsew
process
golgi
enzym
resolv
appar
conflict
experiment
result
explor
three
possibl
explan
effect
bfa
fate
tcr
glycoprotein
one
bfa
block
transport
glycoprotein
er
instead
rapidli
rerout
back
er
reach
medial
golgi
two
bfa
act
gener
block
protein
transport
er
result
accumul
activ
newli
synthes
golgi
enzym
er
three
bfa
induc
redistribut
golgi
enzym
er
prevent
transport
protein
result
strongli
favor
third
hypothesisthat
golgi
enzym
redistribut
golgi
apparatu
er
bfa
treatment
characterist
redistribut
phenomenon
suggest
bfa
may
interfer
normal
recycl
pathway
er
cisl
medial
golgi
effici
block
cycl
pathway
back
er
evid
redistribut
c
medial
golgi
enzym
er
bfamat
cell
examin
fate
golgiresid
protein
cell
treat
bfa
explan
origin
data
emerg
within
minut
addit
bfa
immunofluoresc
microscopi
reveal
dramat
redistribut
medial
golgi
marker
mannosidas
ii
mannosidas
ia
typic
concentr
perinuclear
golgi
pattern
replac
diffus
punctat
stain
coincid
reticular
pattern
er
immunoelectron
microscopi
confirm
impress
fluoresc
pattern
demonstr
clear
stain
er
medial
golgi
protein
found
diffus
throughout
er
includ
nuclear
envelop
contrast
stain
pan
golgi
protein
wga
reveal
protein
redistribut
cislmedi
golgi
marker
distribut
pan
golgi
protein
slowli
chang
respons
bfa
addit
gradual
appear
vesicular
structur
spatial
relationship
er
result
indic
ci
possibl
medial
golgi
rapidli
disassembl
merg
er
respons
bfa
er
retain
structur
thu
glycoprotein
retain
er
process
transport
golgi
fact
tfan
golgi
follow
cislmedi
golgi
er
also
explain
addit
sialic
acid
observ
protein
retain
er
summari
result
effect
bfa
present
tabl
cell
morpholog
result
demonstr
bfa
bring
rapid
complet
redistribut
protein
normal
restrict
medial
golgi
er
redistribut
specif
ci
medial
golgi
protein
redistribut
er
pan
golgi
protein
follow
rout
taken
rest
golgi
system
effect
rapid
order
min
revers
consequ
remov
bfa
cell
demonstr
graphic
rapid
effici
sort
membran
compon
er
golgi
protein
rapidli
remov
er
newli
reform
golgi
cisterna
erresid
protein
mix
remain
er
likewis
tcr
complex
rapidli
recov
abil
transport
er
golgi
onto
distal
target
organel
yet
structur
requir
ertogolgi
transport
retain
thu
cell
ye
complex
despit
golgi
process
carbohydr
chain
remain
trap
within
er
even
remov
bfa
presenc
medial
golgi
enzym
er
may
differ
consequ
oligosaccharid
process
differ
glycoprotein
depend
activ
enzym
lumen
environ
er
thu
oligosaccharid
chain
tcr
rapidli
convert
endo
hresist
form
bfatreat
cell
glycoprotein
oligosaccharid
chain
includ
tcr
vesicular
stomat
viru
g
protein
see
takatsuki
tamura
requir
much
longer
incub
time
bfa
process
event
detect
recent
studi
perkel
et
al
effect
bfa
process
highmannos
oligosaccharid
chain
glycoprotein
er
subcellular
fraction
examin
cell
treat
bfa
observ
accumul
highmannos
oligosaccharid
contain
mannos
residu
instead
mannos
residu
found
control
incub
possibl
mechan
bfa
effect
drug
use
perturb
intracellular
protein
transport
difficult
determin
exact
site
site
action
bfa
whether
drug
singl
mechan
perturb
cellular
function
previou
studi
bfa
demonstr
primarili
interfer
protein
secret
notic
effect
endocytosi
tysosom
degrad
protein
synthesi
misumi
et
al
feel
bfa
act
interf
normal
recycl
pathway
golgi
er
pictur
two
way
could
explain
observ
first
ci
golgi
may
constantli
recycl
back
er
effici
sort
er
return
golgi
bfa
block
latter
step
golgi
would
simpli
continu
recycl
er
remain
second
lipidrich
vesicl
may
constantli
recycl
gotgi
er
without
resid
golgi
protein
would
requir
specif
retent
mechan
keep
protein
within
golgi
stack
allow
lipid
return
er
bfaabrog
golgi
retent
mechan
golgi
protein
could
recycl
lipid
effect
golgi
would
drain
back
er
util
underli
vesicular
recycl
pathway
failur
protein
leav
er
would
consequ
absenc
target
organ
e
ie
ci
golgi
vesicl
leav
er
rather
er
sinc
presenc
bfa
contain
compon
ci
golgi
would
target
vesicl
recycl
golgi
er
recycl
model
transport
golgi
er
provid
resolut
problem
lipid
flow
er
golgi
constant
redistribut
lipid
interlock
recycl
system
would
allow
tremend
lipid
flow
er
return
via
vesicular
transport
mechan
model
would
number
implic
base
previou
studi
rate
membran
flow
recycl
system
would
rapid
wieland
et
al
measur
rate
membran
bulk
flow
er
estim
equival
least
half
surfac
area
er
transport
golgi
everi
min
assum
retriev
massiv
quantiti
lipid
occur
recycl
golgi
apparatu
author
estim
averag
lipid
golgi
would
lifetim
min
recycl
back
er
result
demonstr
rapid
kinet
movement
golgi
protein
er
cell
treat
bfa
return
golgi
upon
remov
drug
consist
estim
implic
protein
recycl
ci
golgi
er
would
transient
mix
golgi
erretain
protein
mix
might
caus
gradual
process
carbohydr
chain
longliv
er
protein
golgi
enzym
two
mechan
might
make
observ
process
event
difficult
perhap
characterist
site
mix
within
either
intermedi
compart
within
region
er
prevent
function
golgi
enzym
second
might
exist
er
repair
mechan
compens
low
rate
golgi
process
either
recycl
newli
synthes
golgi
enzym
erresid
protein
whether
extent
golgi
process
event
occur
er
extens
examin
one
studi
fail
detect
mansgtcnacp
erresid
protein
suggest
cycl
ci
golgi
brand
et
al
howev
recent
data
pelham
demonstr
erretain
protein
modifi
phosphotransferas
believ
local
poster
ci
golgi
compart
increas
attent
focus
vesicular
compart
situat
er
ci
golgi
warren
sarast
kuismanen
schweizer
et
al
compart
site
lowtemperatur
block
ertogolgi
transport
sarast
et
al
also
appear
site
bud
coronavirus
tooz
et
al
perhap
recycl
golgi
occur
intermedi
compart
er
golgi
protein
might
mix
sort
compart
would
analog
endosom
prove
truli
analog
endosom
howev
like
complex
organel
function
structur
underli
explan
effect
bfa
appar
specif
affin
medial
golgi
er
think
coincid
cislmedi
golgi
er
compon
normal
flow
capabl
return
er
interest
respect
medial
golgi
complet
dissoci
tran
golgi
tran
golgi
implic
recycl
pathway
endocyt
organellar
system
perhap
structur
dissoci
observ
tell
us
two
supraorganellar
system
exist
secretoryendocyt
pathway
one
compos
er
intermedi
compart
ci
medial
golgi
second
consist
tram
golgi
tram
golgi
network
endosom
lysosom
plasma
membran
endocyt
pathway
character
drug
perturb
earli
traffick
event
secretori
pathway
great
help
illumin
critic
cellular
process
murin
cell
hybridoma
express
complet
sevenchain
tcr
samelson
et
al
gener
hedrick
et
al
fusion
pigeon
cytochrom
cprime
lymph
node
cell
murin
thymoma
cell
line
murin
thymoma
cell
line
fail
express
c
tcr
chain
bonifacino
et
al
obtain
american
type
cultur
collect
rockvil
md
murin
cell
hybridoma
defici
express
tcr
chain
gener
bonifacino
et
al
unpublish
data
repetit
subclon
limit
dilut
sand
cdefici
variant
cell
follow
transfect
tcr
c
chain
cdna
cell
line
grown
suspend
cell
cultur
describ
samelson
schwartz
nrk
rbl
cell
grown
fetal
bovin
serum
follow
antibodi
use
precipit
tcr
chain
antia
monoclon
murin
bind
chain
express
cell
bamelson
et
al
antiy
polyclon
antiserum
rais
rabbit
immun
purifi
e
chain
anti
monoclon
hamster
igg
bind
murin
e
chain
leo
et
al
rabbit
igg
direct
golgi
mannosidas
ii
moremen
touster
kind
gift
dr
k
moremen
mit
rabbit
igg
direct
golgi
mannosidas
ia
kind
gift
dr
oscar
touster
vanderbilt
univers
rabbit
polyclon
antibodi
erresid
protein
louvard
et
al
gener
provid
dr
louvard
pasteur
institut
pari
franc
rabbit
antipeptid
antibodi
kindli
provid
dr
michael
green
st
loui
univers
rhodamineand
fluoresceinlabel
goat
antirabbit
igg
rhodamineand
fluoresceinlabel
goat
antihamst
igg
hrpconjug
goat
antihamst
f
ab
goat
antirabbit
f
ab
purchas
cooper
biomed
malvern
pa
tokyo
sandoz
co
switzerland
gift
brefeldin
dr
oscar
touster
vanderbilt
univers
kelli
moremen
mit
antibodi
mannosidas
ia
ii
dr
daniel
louvard
pasteur
institut
antier
antibodi
dr
michael
green
st
loui
univers
dr
joe
harford
valuabl
scientif
discuss
thank
dr
stuart
kornfeld
suggest
use
swainsonin
experl
mr
kati
perri
provid
excel
assist
prepar
manuscrtpt
cost
public
articl
defray
part
payment
page
charg
articl
must
therefor
herebi
mark
adverfis
accord
usc
section
sole
indic
fact
receiv
octob
revis
decemb
